4//SEC Filing
Riker Lauren Bullaro 4
Accession 0001209191-23-041865
CIK 0001396814other
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 8:04 PM ET
Size
5.9 KB
Accession
0001209191-23-041865
Insider Transaction Report
Form 4
RIKER LAUREN
Senior Vice President, Finance
Transactions
- Sale
Common Stock
2023-07-05$38.91/sh−643$25,019→ 22,687.335 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.67 to $39.40, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]Includes 643.335 shares of common stock acquired under the issuer's employee stock purchase plan in June 2023.
Documents
Issuer
Pacira BioSciences, Inc.
CIK 0001396814
Entity typeother
Related Parties
1- filerCIK 0001545439
Filing Metadata
- Form type
- 4
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 8:04 PM ET
- Size
- 5.9 KB